(Date:11/25/2009)...lar cancer who were treated with cisplatin-based c...g neurological side effects and Raynaud-like pheno...apy, according to a new study published online Nov...stitute . , Marianne Brydy, M.D., of the Departm... Bergen, Norway, and colleagues conducted a cross-...
(Date:11/25/2009)...grew out of a collaboration between UCLA engineers...e nearly 10 million Americans who suffer from peri...dening of the arteries, peripheral arterial diseas...h narrowed arteries reduce blood flow to the limbs...lar disease, heart attack and stroke, and its prog...
(Date:11/25/2009)...oo short to draw definite conclusions, experts say...s) -- In diabetic patients with blocked coronary a...omes at one year whether patients undergo bypass s...rchers report. , Bypass surgery has been the st...ry artery disease. However, less invasive approach...
(Date:11/25/2009)...tion and treatment clinics to resume Monday, Nov. ...vember 25, 2009 -- Centegra Health System is conti...e shots at four Centegra Primary Care (CPC) vaccin...s arrived. The clinics are at CPC sites in Huntley...open as follows: , From 4:30 to 7:30...
(Date:11/25/2009)...logical symptoms, study finds , , WEDNE...e effects are among the potential problems faced b...e treated with cisplatin-based chemotherapy, a new...rwegian men treated for unilateral testicular canc...-up survey conducted from 1998 to 2002. , The r...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4... British study says that Man's best friend might b...tionally sensitive noses, // dogs can smell odors ...gs of varying breeds and ages were trained over se...m six control group participants and one bladder c...
...vention program designed to educate parents about ...toms of asthma in children // say researchers .M...e children were allergic to at least one indoor en...nately high rate.
Researchers designed an inter...
...sillectomy is a common procedure in children , eve...ses with milder symptoms.// A new study suggests t...tonsils and adenoids in children with mild throat ... had the surgery, and half were allocated to watch...
...ers from several international centers combined ef...educing risk factors for disease. They looked at 2..., alcohol use, unsafe water, sanitation and hygien...d the world in 2000 resulted from a combination of...
...y, lung cancer is the leading cause of cancer deat...search shows women // have double the risk of deve...searchers in New York studied nearly 3,000 men and...bability of developing lung cancer. To best determ...
...udy confirms the recommendation by the American He... water-soluble fiber,// is beneficial to your hear...between dietary fiber intake and the reduction of ...disease and cardiovascular disease.
The study i...
Other Medicine News:Health News:High Fiber Diet Found To Protect The Heart 2(Date:11/25/2009)...Newswire/--BioTrendsResearchGroup,Inc.releasedWave...rstinamulti-phasesyndicatedmarketresearchprojecttr...omproductlaunchthroughthefirstsixmonthsofavailabil...tionfrom75uniqueDermatologistsandqualitativeinform...Stelara,obstaclestouse,typicalpatienttypes,product...
(Date:11/25/2009)...ov.25/PRNewswire/--RegadoBiosciences,aprivatelyhel...erswithactivecontrolagents,announcedthatDavidMazzo...fray21stAnnualHealthCareConferenceattheNewYorkPala...ivenat1:10pm(EST)onTuesday,December1andwillinclude...eaddevelopmentprogram,theanticoagulantsystem,REG1....
(Date:11/25/2009)...Nov.25/PRNewswire/--SwissrayInternational,Inc.alea...ystems,announcedtodaythatitsoperationshavebeenacqu...sgrowingSwissray,smedicalimagingbrand.Theacquisiti...scontractsandinventory.After25yearsofsuccessandgro...logicaladvancementswithstableandsteadygrowth. ,...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 1Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 2Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 3John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 1John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 2John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 3Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 1Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 2...9, 2007 /PRNewswire-FirstCall/ - YM,BioSciences In...,and commercializes differentiated products for pa...sented by investigators from Kinki,University Scho...eting of The Japanese Association for Molecular Ta...nstrated the increased,radiosensitivity of human N...
...INESS WIRE)--July 9, 2007 - NexMed, Inc.,(NASDAQ: ...ments,based on the NexACT(R) drug delivery technol...ompleted patient enrollment for Phase,III clinical...homycosis (nail fungus). Pursuant to the terms of ... be entitled to a milestone,payment early next yea...
Other Medicine Technology:YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product 2Ovation BioNatural Pipette, one-stroke, fixed volume, 200L
Finnpipette Fixed Volume, 200ul
Pipetman F100
Eppendorf Research Series 2100 Fixed-volume Pipette, 100 l
Medicine Products: